DGAP-News: Celesio AG: Revenue and earnings in the first

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: Celesio AG: Revenue and earnings in the first nine months 2014 up on prior year

DGAP-News: Celesio AG / Key word(s): 9-month figures Celesio AG: Revenue and earnings in the first nine months 2014 up on prior year 28.10.2014 / 07:00 --------------------------------------------------------------------- Celesio: Revenue and earnings in the first nine months 2014 up on prior year Ongoing discount competition in Germany and challenging market environment in France and Brazil anticipated Stuttgart, 28 October 2014. Celesio generated group revenue of 16,460.0 million euro in the first nine months of 2014, which is up 2.9 per cent year-on-year. When adjusted for currency effects and changes in the consolidated group, revenue actually increased by 3.7 per cent. Market growth in Germany and Brazil and the good revenue performance in the United Kingdom and Norway outweighed the decline in France and Belgium. Adjusted earnings before interest and taxes (EBIT) rose by 2.1 per cent from 312.0 million euro to 318.7 million euro. This is mainly due to the very good performance in the United Kingdom and Norway which more than compensated for the challenging circumstances caused by the discount competition in Germany, the weak market in France and an unfavourable trend in Brazil. In the first nine months of 2014 Net Financial Debt decreased by 281.3 million euro to 1,082.1 million euro, which can be attributed in particular to the conversion of the 2014 and 2018 convertible bonds. "The operational performance in the first nine months of 2014 is in line with our expectations," confirms Marc Owen, Chairman of the Management Board. "Future development will hinge on how quickly the international platform can be set up after the registration of the domination and profit and loss transfer agreement. Therefore an integration team is tasked with identifying areas of potential, preparing solutions and then effecting a gradual integration into the organisational structure of McKesson. A leadership team has been set up to define the strategic and operating priorities. I feel very confident that this team will strengthen the position of Celesio as a leading international wholesale and retail company in the pharmaceutical and healthcare sector in the short term." Performance in the divisions Revenue in the Consumer Solutions division - the pharmacy business - increased by 7.6 per cent from 2,514.8 million euro to 2,706.0 million euro. After adjustments for currency effects, revenue rose by 5.7 per cent. After adjustments for non-recurring effects, EBIT increased significantly by 15.9 per cent from the prior year's figure of 144.5 million euro to 167.4 million euro in 2014. Revenue in the Pharmacy Solutions division - the wholesale business - increased by 2.1 per cent to 13,754.5 million euro. After adjustments for currency effects, revenue increased by 2.8 per cent. After adjustments for non-recurring effects, EBIT fell significantly by 10.4 per cent. Earnings forecast Optimising the company's cost structures and level of efficiency is fundamental. The expansion of the European Pharmacy Network will also have a positive impact, enabling even stronger growth from 2015 onwards. However, these revenues will still be reduced in part by IT project costs in 2014. The unfavourable situation in Germany, France and Brazil is affecting earnings more than previously expected. The group has also faced higher allowances for debts in Portugal. Overall, adjusted EBIT in the 2014 fiscal year is expected to be slightly lower than in the prior year. <pre> Key figures of the 1st to 3rd 1st to 3rd Change Celesio Group quarter 2013 quarter 2014 on EUR basis in % Continuing operations Revenue EUR m 15,991.1 16,460.0 2.9 EBITDA EUR m 399.3 369.5 -7.5 adjusted1) EUR m 406.9 410.2 0.8 EBIT EUR m 303.3 173.7 -42.7 adjusted1) EUR m 312.0 318.7 2.1 Net profit/loss EUR m 126.2 37.6 -70.2 adjusted1) EUR m 132.1 174.0 31.7 Free cash flow EUR m 33.3 -271.5 Discontinued operations Net profit/loss EUR m -5.4 -0.9 83.4 Continuing and discontinued operations Net Financial Debt EUR m 1,363.42) 1,082.13) -20.6 Net Financial Debt/ 2.492) 1.963) / EBITDA adj. 1) 4) Retail pharmacies3) 2,176 2,184 / Wholesale branches3) 131 133 / Employees3) 38,886 38,593 / Net profit (for the EUR m 120.8 36.7 / period) Earnings per share EUR 0.68 0.18 / (basic) </pre> 1) Adjusted for non-recurring effects from defined non-recurring expenses and income (including tax effect). 2) Closing figures as at 31 December 2013. 3) Closing figures at the end of the reporting period. 4) Based on EBITDA of the last twelve months. Press Contact Marc Binder, Celesio AG, +49 (0) 711.5001-380 media@celesio.com Rainer Berghausen, Celesio AG, +49 (0) 711.5001-549 media@celesio.com Investor Relations Markus Georgi, Celesio AG, +49 (0) 711.5001-1208. investor@celesio.com. Michael Otto, Celesio AG, +49 (0) 711.5001-635 investor@celesio.com Creditor Relations Marcus Hilger, Celesio AG, +49 (0) 711.5001-532 finance@celesio.com Tobias Mommertz, Celesio AG, +49 (0) 711.5001-395 finance@celesio.com About the Celesio Group Celesio is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care. With some 39,000 employees, Celesio operates in 14 countries around the world. Every day, the group serves over 2 million customers - at about 2,200 pharmacies of its own and over 4,300 participants in brand partnership schemes. With 133 wholesale branches, Celesio supplies 65,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products. The services benefit a patient pool of about 15 million per day. --------------------------------------------------------------------- 28.10.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Celesio AG Neckartalstr. 155 70376 Stuttgart Germany Phone: +49 (0)711 5001-735 Fax: +49 (0)711 5001-740 E-mail: investor@celesio.com Internet: www.celesio.com ISIN: DE000CLS1001 WKN: CLS100 Indices: MDAX Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime Standard), München, Stuttgart; Freiverkehr in Hamburg, Hannover; Terminbörse EUREX End of News DGAP News-Service --------------------------------------------------------------------- 293599 28.10.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 55

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 0

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 159

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 197

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Yeahka Bids to Lead AI Shopping Evolution

Updated Category News Views 115

AI Shopping: A New Frontier or A Sisyphean Task? The evolution of AI from sassy recommendation tools to transaction-executing agents is shaking up the retail sector. Enter Stage Left: Yeahka Limited (9923.HK), a payment tech outfit that's wading into this murky digital swamp. With YeahPay and Fushi Tech, they're trying to hammer out a blueprint for AI-friendly commerce...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 175

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 0

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 148

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 11

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 72

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading

Top 5 Most Recently Viewed Articles

IASO Bio Achieves Major Milestone with Orphan Drug Status

Updated Category News Views 270

IASO Bio Earns Orphan Drug Designation for Breakthrough Therapy IASO Biotherapeutics, a key player in the biopharmaceutical sector, announced an exciting achievement as its groundbreaking treatment, Equecabtagene Autoleucel (Fucaso), received Orphan Drug Designation from the Ministry of Food and Drug Safety. This recognition is particularly significant for adults fighting...

Continue Reading
Transforming Experience: Honda Center's $1 Billion Revamp

Updated Category News Views 387

Transforming Experience: Honda Center's $1 Billion Revamp Honda Center Encore Is A Multi-Year Investment Led by the Samueli Family That Will Redefine the Arena Experience OC Sports & Entertainment (OCSE), connected with the operator of Honda Center, has announced a groundbreaking project known as Honda Center Encore. This ambitious venture involves a significant...

Continue Reading
PIMCO Municipal Income Fund Faces Market Pressures at New Lows

Updated Category News Views 192

PIMCO Municipal Income Fund's Recent Market Performance PIMCO Municipal Income Fund (PMF) has recently faced significant market challenges, as evidenced by its stock hitting a notable 52-week low at a price of $8.82. This decline isn't merely an isolated incident; it reflects ongoing pressures impacting the broader fixed-income sector. Investors are currently navigating...

Continue Reading
Exploring Non-Surgical Solutions for Prostate Health Issues

Updated Category News Views 174

Prostate health became a hot topic for many men over 50, especially with the rise of benign prostatic hyperplasia (BPH)—that uncomfortable enlargement that turns bathroom trips into sprints. Back then, treatment options were shaking up, and PAE was coming onto the scene like it owned the place. PAE vs. Traditional Surgery: The Fight for Relief In an era where...

Continue Reading
Applied Digital Appoints Laura Laltrello as COO for AI Growth

Updated Category News Views 245

Applied Digital Names Laura Laltrello as New COO Applied Digital Corporation (NASDAQ: APLD) is excited to announce the appointment of Laura Laltrello as its new Chief Operating Officer (COO). With an aim to strengthen the Company’s leadership in next-generation data centers and digital cloud solutions, Ms. Laltrello's role signifies a pivotal moment in the Company’s...

Continue Reading